Use your browser's back button to choose another title or click here for a New Search.

How to Get the Article

 Email CTN Library (free)

PubMed Central (free)

Journal subscriber access




Bookmark and Share

Depressive Symptoms, Substance Use and HIV-Related High Risk Behaviors among Opioid-Dependent Individuals: Results from the Clinical Trials Network.

Substance Use & Misuse 2011;46(14):1716-1725. [doi: 10.3109/10826084.2011.611960]

Daniel J. Pilowsky, MD (New York State Psychiatric Institute, GNY Node), Li-Tzy Wu, ScD (Duke University Medical Center, CTN Data & Statistics Center), Bruce Burchett (Duke University Medical Center, CTN Data & Statistics Center), Dan G. Blazer, MD, PhD (Duke University Medical Center, CTN Data & Statistics Center), Walter Ling, MD (Integrated Substance Abuse Programs, PR Node).

This article reports on an ancillary investigation of data from protocols CTN-0001 and CTN-0002 (Buprenorphine/Naloxone versus Clonidine for Inpatient/Outpatient Opiate Detoxification). The sample included 343 opioid-dependent adults enrolled in the protocols. Researchers examined associations between depressive symptoms, co-occurring substance use (i.e., the use of substances other than opioids), and HIV-related sexual and injection risk behaviors. Data were collected using the Addiction Severity Index and the HIV Risk Behavior Scale, and analyzed using linear regression. Depressive symptoms were associated with an increased level of injection risk behaviors but were not associated with risky sexual behaviors. The co-occurring use of amphetamines also increased the likelihood of risky sexual behaviors.

Outcomes: Treatment of depression can make a contribution to decreasing injection risk among opioid-dependent injection drug users, expecially if combined with other risk reduction interventions. This study also revealed that noninjecting amphetamine use was independently associated with sexual risk behaviors among opioid-dependent individuals. (Article (Peer-Reviewed), PDF, English, 2011)

Keywords: Addiction Severity Index (ASI) | Amphetamines | Buprenorphine/Naloxone | Co-occurring disorders | CTN platform/ancillary study | Depression | HIV/AIDS | HIV Risk Behavior Scale (HRBS) | Injection drug use | Opioid dependence | Pharmacological therapy | Sexual risk behavior | Sexually transmitted diseases | Suboxone | Substance Use & Misuse (journal)

Document No: 754, PMID: 21973307, PMCID: PMC3394674.

Submitted by the CTN Dissemination Librarians (10/7/2011).

Blazer, Dan G. search mail
Burchett, Bruce search
Ling, Walter search mail
Pilowsky, Daniel J. search
Wu, Li-Tzy search mail
NIDA-CTN-0001 search www
NIDA-CTN-0002 search www
Pacific Region (Lead) search www
Delaware Valley search www
Florida Node Alliance search www
Great Lakes Regional search www
Greater New York (formerly Long Island and New York) search www
Ohio Valley search www
Western States (formerly Oregon/Hawaii) search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 10/2012 --